Israel’s state-supported Galilee Research Institute (Migal) is known to be working on a cutting edge COVID-19 treatment, but human testing of the vaccine is only expected to start in June, and production, delivery and sale of the drug only after that.
Israel’s Migal Galilee Research Institute has issued a fraud notice warning residents of nations in South America not to buy or use a product falsely labeled as a coronavirus vaccine developed by the institute.
Continue reading https://sptnkne.ws/C69b